Dr. Kircik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1169 Eastern Pkwy 2310
Louisville, KY 40217Phone+1 502-456-2783Fax+1 502-456-2728
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Surgery, 1994 - 1994
- University at Buffalo School of MedicineResidency, Dermatology, 1990 - 1993
- Westchester Medical CenterInternship, Internal Medicine, 1989 - 1990
- State University of New York Downstate Medical Center College of MedicineClass of 1989
Certifications & Licensure
- NJ State Medical License 1993 - Present
- NY State Medical License 1990 - 2026
- TX State Medical License 2022 - 2026
- VA State Medical License 1998 - 2026
- IN State Medical License 1998 - 2025
- KY State Medical License 1996 - 2025
- WI State Medical License 1994 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis Start of enrollment: 2006 Mar 01
- Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis Start of enrollment: 2007 Feb 01
- A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: poole...Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge
The Journal of Dermatological Treatment. 2025-12-01 - Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from T...Eric L Simpson, Matthias Augustin, Diamant Thaçi, Laurent Misery, April W Armstrong
American Journal of Clinical Dermatology. 2025-01-01 - 4 citationsThe primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management.James Q Del Rosso, Leon Kircik
The Journal of Dermatological Treatment. 2024-12-01
Journal Articles
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisLeon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine
Authored Content
- Polymorphous Light Eruptions Treated with Roflumilast 0.3% Cream: A Case ReportAugust 2024
- Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With PsoriasisJanuary 2024
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020
Press Mentions
- Patient Preferences in Topical Psoriasis TreatmentMarch 18th, 2023
- Intralesional Mode of Drug Administration in PsoriasisJanuary 26th, 2022
- LiVDerm Announces New South Beach Symposium Planning Committee & Advisory BoardApril 20th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: